Biotech · Private company
Symbiomix Therapeutics
Track this companyFree. Adds Symbiomix Therapeutics to your Dealase workspace and tells you when its record changes.
Clinical trials30 recruiting or active
Pipeline programs1From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline1
- SYM-1219Phase 3 · Bacterial VaginosisClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- Open-Label Study to Evaluate Safety of A Single Dose of SYM-1219PHASE3 · COMPLETED · started Jun 1, 2015ClinicalTrials.gov NCT02452866 · fetched Nov 12, 2026
- A Phase 3 Study of SYM-1219 Treatment of Women and Post-Menarchal Adolescent Girls With Bacterial VaginosisPHASE3 · COMPLETED · started May 28, 2015ClinicalTrials.gov NCT02418845 · fetched Nov 12, 2026
- A Phase 2 Study of SYM-1219 to Treat Bacterial VaginosisPHASE2 · COMPLETED · started May 1, 2014ClinicalTrials.gov NCT02147899 · fetched Nov 12, 2026